癌症患者的眼面整形手术:一个叙事审查
Carson E Clabeaux1, Harkaran S Rana2, Amol H Patadia3
1Department of Ophthalmology, Madigan Army Medical Center, Tacoma, Washington, USA.
European journal of ophthalmology
|December 9, 2024
概括
接受治疗或缓解的癌症患者需要特别的外科考虑. 系统疗法和放射疗法显著影响患者生理和组织完整性,影响眼面整形外科医生的手术结果.
科学领域:
- 眼面外科整形手术 眼面外科整形手术
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 由于系统治疗和放射治疗的进步,癌症存活率正在增加.
- 眼面整形外科医生必须意识到癌症患者所面临的独特挑战.
- 患者护理需要了解癌症治疗对手术候选和结果的影响.
研究的目的:
- 审查眼面整形外科医生管理有癌症史或正在接受癌症治疗的患者的关键考虑因素.
- 突出系统疗法和放射治疗如何影响手术规划和患者生理学.
- 强调外科医生对癌症对手术结果的影响意识的重要性.
主要方法:
- 使用PubMed,Embase和谷歌学者进行了全面的文献搜索.
- 关键词包括癌症治疗的组合 (化疗,免疫疗法,放射疗法) 和手术方面 (眼膜,轨道,眼皮,面部塑料,伤口愈合,感染,出血).
- 对1993年至2023年间发表的89篇文章进行了审查,包括基础和引用参考.
主要成果:
- 系统疗法和放射疗法对患者生理有深远的影响.
- 组织完整性受到损害,影响伤口愈合,感染风险和潜在的出血.
- 这些治疗方式需要特定的术前和术后管理策略.
结论:
- 眼面整形外科医生必须对癌症治疗对手术结果的影响有充分的了解.
- 对于正在接受活跃癌症治疗或正在缓解的患者,必须特别考虑.
- 有信息的外科决策需要将瘤疗法知识整合到眼面整形手术实践中.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...